Stock Price Quote

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE885.5533.35 (+3.91 %)
PREV CLOSE ( ) 852.20
OPEN PRICE ( ) 860.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 49330
TODAY'S LOW / HIGH ( )851.15 905.00
52 WK LOW / HIGH ( )450 931.7
NSE886.7034.75 (+4.08 %)
PREV CLOSE( ) 851.95
OPEN PRICE ( ) 869.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 886.70 (7037)
VOLUME 746329
TODAY'S LOW / HIGH( ) 851.25 905.50
52 WK LOW / HIGH ( )402.55 929.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500003

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX

NEWS

25Sep Natco Pharma informs about disclosure
Natco Pharma has informed that the exchange has received the disclosure..
22Sep SBI Life Insurance, IOC and Natco Phar
SBI Life Insurance Company has signed bancassurance agreement with Yes B..
21Sep Natco Pharma aims to diversify product
Natco Pharma is planning to diversify its product portfolio in the domes..
10Sep Natco Pharma informs about outcome of
Natco Pharma has informed that the Board of Directors of the Company at..
03Aug Natco Pharma informs about board meeting
Natco Pharma has informed that the meeting of the Board of Directors of..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit12674745
Gross Profit 1616 5831
Operating Profit 19257018
Net Sales 532217902

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  16206.65 (1.49%)
M.Cap ( in Cr)34438.00
Sanofi India (BSE)
peergroup  8558.35 (2.11%)
M.Cap ( in Cr)19710.41
Aarti Drugs (BSE)
peergroup  2952.40 (4.69%)
M.Cap ( in Cr)6879.09
Dr. Reddys Lab (BSE)
peergroup  5114.05 (1.78%)
M.Cap ( in Cr)85030.94
Astrazeneca Pharma I (BSE)
peergroup  4300.60 (2.07%)
M.Cap ( in Cr)10751.50

Shareholding Pattern

MUTUAL FUNDS/UTI 8.67%
PROMOTERS 48.93%
NON-INSTITUTION 17.85%
FI/BANKS/INSURANCE 0.22%
GOVERNMENT 0%
FII 0%

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 885.55. Its current market capitalisation stands at Rs 16133.51 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20582 Cr and Total Income of Rs.20224 Cr. The company's management includes Sridhar Sankararaman, D Linga Rao, PSRK Prasad, Rajeev Nannapaneni, MUR Naidu, Leela Digumarti, DG Prasad, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, BSR & Associates LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)